Walmart's "everyday low prices" should attract customers even if a recession comes. Which group of individuals is in the best ...

Health care stocks have outperformed so far in 2025 despite uncertainty surrounding the new Donald Trump administration. Health care stocks can often be a solid defensive play in an uncertain economy.

Trump's new tariff move may raise U.S. pharma costs, with analysts warning of risks tied to EU manufacturing and shifting healthcare policies.

J.P. Morgan analyst Jessica Fye maintained a Buy rating on Mirum Pharmaceuticals (MIRM – Research Report) today and set a price target of ...

Explore the top-performing Nasdaq 100 stocks this year as the index moves into a technical bear market this year.

In a report released yesterday, Whitney Ijem from Canaccord Genuity reiterated a Buy rating on Alnylam Pharma (ALNY – Research Report), with a ...

Cellular Therapies and IDRx, crossed the $1 billion mark, a notable decrease from the six seen during the same period last year.

Learn more about whether Alkermes plc or Moderna, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Artis BioSolutions joins a host of startups trying to improve development and manufacturing capacity for cutting-edge gene ...

Sellers ruled in the stock market today after China retaliated with a 34% tariff on all imported goods from the U.S. Nike ...

Major indices were firmly in the red early on Friday as Donald Trump's tariff-driven market rout looked set to continue for ...